Division of Gastroenterology, McGill University Health Center, Montreal, Québec, Canada.
Division of Gastroenterology, University of California San Diego, La Jolla, California.
Inflamm Bowel Dis. 2018 Nov 29;24(12):2518-2526. doi: 10.1093/ibd/izy188.
We assessed the comparative efficacy of different dysplasia detection techniques in patients with ulcerative colitis (UC) through a network meta-analysis and rated the quality of evidence using GRADE approach.
Through a systematic literature review of multiple databases through June 30, 2017, we identified parallel-group randomized controlled trials (RCTs) in adults with long-standing UC undergoing surveillance colonoscopy with standard definition-white light endoscopy (SD-WLE), high-definition WLE (HD-WLE), narrow band imaging (NBI), or dye-based chromoendoscopy. The primary outcome was the total number of dysplastic lesions. Pairwise and network meta-analysis was performed; ranking was assessed using surface under the cumulative ranking (SUCRA) probabilities.
Based on 8 parallel-group RCTs (924 patients), low-quality evidence supports chromoendoscopy over SD-WLE (odds ratio [OR], 2.37; 95% credible interval [CrI], 0.81-6.94) for any dysplasia detection, whereas very low-quality evidence supports using HD-WLE or NBI over SD-WLE (HD-WLE [vs SD-WLE]: OR, 1.21; 95% CrI, 0.30-4.85; NBI: OR, 1.68; 95% CrI, 0.54-5.22). Very low-quality evidence from indirect comparative analysis supports the use of chromoendoscopy over HD-WLE (OR, 1.96; 95% CrI, 0.72-5.34) or NBI (OR, 1.41; 95% CrI, 0.70-2.84) for any dysplasia detection. The number of patients with advanced neoplasia was very small, precluding meaningful analysis.
Although we did not find any single technique to be superior, chromoendoscopy is probably more effective than SD-WLE for detecting any dysplasia, and there is low confidence in estimates supporting its use over HD-WLE or NBI. There is very low-quality evidence to inform the comparative efficacy of these interventions in detecting advanced neoplasia or preventing future colorectal cancer. Pragmatic, parallel-group RCTs with longitudinal follow-up are warranted to inform optimal dysplasia surveillance techniques. 10.1093/ibd/izy188_video1izy188.video15789702674001.
我们通过网络荟萃分析评估了溃疡性结肠炎(UC)患者中不同的发育不良检测技术的比较疗效,并使用 GRADE 方法对证据质量进行了评级。
通过对截至 2017 年 6 月 30 日的多个数据库进行系统的文献检索,我们鉴定了接受标准白光内镜(SD-WLE)、高清白光内镜(HD-WLE)、窄带成像(NBI)或染色内镜监测的长病程 UC 成人的平行组随机对照试验(RCT)。主要结局为异型增生病变的总数。进行了两两比较和网络荟萃分析;使用累积排序概率(SUCRA)评估排名。
基于 8 项平行组 RCT(924 例患者),低质量证据支持染色内镜优于 SD-WLE(优势比[OR],2.37;95%可信区间[CrI],0.81-6.94)用于任何异型增生检测,而极低质量证据支持 HD-WLE 或 NBI 优于 SD-WLE(HD-WLE [与 SD-WLE 相比]:OR,1.21;95% CrI,0.30-4.85;NBI:OR,1.68;95% CrI,0.54-5.22)。间接比较分析的极低质量证据支持染色内镜优于 HD-WLE(OR,1.96;95% CrI,0.72-5.34)或 NBI(OR,1.41;95% CrI,0.70-2.84)用于任何异型增生检测。高级别肿瘤的患者数量非常少,无法进行有意义的分析。
尽管我们没有发现任何一种技术具有优势,但染色内镜可能比 SD-WLE 更有效地检测任何异型增生,并且对其优于 HD-WLE 或 NBI 的使用的估计置信度较低。这些干预措施在检测高级别肿瘤或预防未来结直肠癌方面的比较疗效的证据质量非常低。需要进行具有纵向随访的实用平行组 RCT 来确定最佳的异型增生监测技术。10.1093/ibd/izy188_video1izy188.video15789702674001.